Literature DB >> 17762737

Early plasma complement C3a levels correlate with functional outcome after aneurysmal subarachnoid hemorrhage.

William J Mack1, Andrew F Ducruet, Zachary L Hickman, Matthew C Garrett, Eli J Albert, Christopher P Kellner, J Mocco, E Sander Connolly.   

Abstract

OBJECTIVE: Studies have documented an inflammatory response in the circulating plasma and cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage (aSAH). In particular, early upregulation of several complement proteins, including C3a, C4a, and C5b-9, has been demonstrated after the initial hemorrhagic insult. The inflammatory actions of the complement cascade are largely mediated through the anaphylatoxins, C3a and C5a. Recent investigations have established a critical role for C3a in the pathogenesis of cerebral ischemia. We attempt to confirm that plasma C3a and C5a values are elevated in patients with aSAH and to determine whether or not these levels are reliable independent predictors of functional outcome irrespective of clinical presentation.
METHODS: Fifty-two patients with aSAH were prospectively enrolled and stratified according to admission Hunt and Hess grade, demographic variables, and functional status at the time of discharge (modified Rankin Scale score). Plasma C3a and C5a levels were determined at early and late time points after aSAH through enzyme-linked immunosorbent assay.
RESULTS: After aSAH, early C3a and C5a values were increased compared with levels in non-SAH control patients (P < 0.001). Univariate analysis demonstrated that elevations in early C3a (P = 0.010) and C5a (P = 0.041) levels and poor admission Hunt and Hess grade (P = 0.015) correlated significantly with unfavorable outcome. In our multivariate model, only early C3a levels retained a strong correlation with outcome when modeled with Hunt and Hess grade (P = 0.009).
CONCLUSION: These results demonstrate an association between early complement C3a levels and outcome after aSAH that seems to be independent of the initial hemorrhage. The findings suggest that inflammatory processes involving C3a may contribute to delayed morbidity and mortality after aneurysmal rupture.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17762737     DOI: 10.1227/01.NEU.0000255518.96837.8E

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  18 in total

Review 1.  The complement cascade as a therapeutic target in intracerebral hemorrhage.

Authors:  Andrew F Ducruet; Brad E Zacharia; Zachary L Hickman; Bartosz T Grobelny; Mason L Yeh; Sergey A Sosunov; E Sander Connolly
Journal:  Exp Neurol       Date:  2009-07-24       Impact factor: 5.330

Review 2.  Complement inhibition as a proposed neuroprotective strategy following cardiac arrest.

Authors:  Brad E Zacharia; Zachary L Hickman; Bartosz T Grobelny; Peter A DeRosa; Andrew F Ducruet; E Sander Connolly
Journal:  Mediators Inflamm       Date:  2010-01-26       Impact factor: 4.711

Review 3.  Current management of delayed cerebral ischemia: update from results of recent clinical trials.

Authors:  Shakira Brathwaite; R Loch Macdonald
Journal:  Transl Stroke Res       Date:  2013-12-13       Impact factor: 6.829

4.  Polymorphisms in complement component 3 (C3F) and complement factor H (Y402H) increase the risk of postoperative neurocognitive dysfunction following carotid endarterectomy.

Authors:  Paul R Gigante; Ivan S Kotchetkov; Christopher P Kellner; Raqeeb Haque; Andrew F Ducruet; Brian Y Hwang; Robert A Solomon; Eric J Heyer; E Sander Connolly
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-09-14       Impact factor: 10.154

5.  The role of the complement system and the activation fragment C5a in the central nervous system.

Authors:  Trent M Woodruff; Rahasson R Ager; Andrea J Tenner; Peter G Noakes; Stephen M Taylor
Journal:  Neuromolecular Med       Date:  2009-09-11       Impact factor: 3.843

Review 6.  Genetic determinants of cerebral vasospasm, delayed cerebral ischemia, and outcome after aneurysmal subarachnoid hemorrhage.

Authors:  Andrew F Ducruet; Paul R Gigante; Zachary L Hickman; Brad E Zacharia; Eric J Arias; Bartosz T Grobelny; Justin W Gorski; Stephan A Mayer; E Sander Connolly
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-13       Impact factor: 6.200

Review 7.  Biomarkers as outcome predictors in subarachnoid hemorrhage--a systematic review.

Authors:  Caron M Hong; Cigdem Tosun; David B Kurland; Volodymyr Gerzanich; David Schreibman; J Marc Simard
Journal:  Biomarkers       Date:  2014-02-05       Impact factor: 2.658

8.  CCR2+ Ly6C(hi) inflammatory monocyte recruitment exacerbates acute disability following intracerebral hemorrhage.

Authors:  Matthew D Hammond; Roslyn A Taylor; Michael T Mullen; Youxi Ai; Hector L Aguila; Matthias Mack; Scott E Kasner; Louise D McCullough; Lauren H Sansing
Journal:  J Neurosci       Date:  2014-03-12       Impact factor: 6.167

9.  C3a receptor antagonist attenuates brain injury after intracerebral hemorrhage.

Authors:  Michal A Rynkowski; Grace H Kim; Matthew C Garrett; Brad E Zacharia; Marc L Otten; Sergei A Sosunov; Ricardo J Komotar; Benjamin G Hassid; Andrew F Ducruet; John D Lambris; E Sander Connolly
Journal:  J Cereb Blood Flow Metab       Date:  2008-08-27       Impact factor: 6.200

Review 10.  The role of complement in brain injury following intracerebral hemorrhage: A review.

Authors:  Katherine Holste; Fan Xia; Hugh J L Garton; Shu Wan; Ya Hua; Richard F Keep; Guohua Xi
Journal:  Exp Neurol       Date:  2021-02-20       Impact factor: 5.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.